Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of levamlodipine + bisoprolol fixed-dose tablet in primary hypertension inadequately controlled after levamlodipine or bisoprolol monotherapy
CTR20240049Phase 3Active
- Sponsor
- Shihuida Pharmaceutical Group
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Levamlodipine, bisoprolol in essential hypertension, sponsored by Shihuida Pharmaceutical Group. Started Feb 2024; status: active.
02
Drugs
Levamlodipinebisoprolol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20240049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240049.